Australia - English - Department of Health (Therapeutic Goods Administration)

kinetix lifesciences pty ltd - 61325 - bone-screw internal spinal fixation system, non-sterile - gs medical spinal fixation systems are indicated for temporary or permanent correction or stabilization of the vertebral column from the thoracic to the sacrum and with the aim of helping consolidation or bone fusion. gs medical spinal fixation systems are designed for posterior fixation procedure.

United States - English - NLM (National Library of Medicine)

thefaceshop co. ltd. - octinoxate • • • • • • • • • • • • • • • • • • 5.0% titanium dioxide • • • • • • • • • • • • • • 7.8% zinc oxide • • • • • • • • • • • • • • • • • • • .3.0% - sunscreen sunscreen sunscreen

United States - English - NLM (National Library of Medicine)

saturday9 co., ltd. - glycine soja (soybean) seed extract, peat water 0.002% glycerin 3% salicylic acid 0.25% dexpanthenol 0.2% mental 0.3% - glycine soja (soybean) seed extract 0.01% hair loss relief peat water 0.002% hair-loss relief glycerin 3% skin protectant salicylic acid 0.25% hair-loss relief dexpanthenol 0.2% hair-loss relief mental 0.3% hair-loss relief hair loss relief, scalp & hair nutrition, scalp cleaning care

United States - English - NLM (National Library of Medicine)

saturday9 co., ltd. - glycine soja (soybean) seed extract 2% peat water 0.015% glycerin 0,0075% salicylic acid 0.2% dexpanthenol 0.2% niacinamide 0.1% - glycine soja (soybean) seed extract 2% hair-loss relief peat water 0.015% hair-loss relief glycerin 0,0075% skin protectant salicylic acid 0.2% hair loss relief dexpanthenol 0.2% hair loss relief niacinamide 0.1% hair loss relief hair loss relief through cleansing the scalp and supplying nutrients for healthy hair

United States - English - NLM (National Library of Medicine)

saturday9 co., ltd. - glycine soja (soybean) seed extract 0.01% peat water 0.002% glycerin 3% salicylic acid 0.25% dexpanthenol 0.2% mentol 0.3% - glycine soja (soybean) seed extract 0.01% hair-loss relief peat water 0.002% hair-loss relief glycerin 3% skin protectant salicylic acid 0.25% hair loss relief dexpanthenol 0.2% hair loss relief mentol 0.3% hair loss relief hair loss relief, scalp calming, scalp cooling

United States - English - NLM (National Library of Medicine)

barona co., ltd - hydrogenated soybean oil (unii: a2m91m918c) (hydrogenated soybean oil - unii:a2m91m918c) - lipolytic hyperlipidemia elimination skin elasticity recovery apply to skin and massage wait for about 1 hour wash away with clean water.

United States - English - NLM (National Library of Medicine)

barona co., ltd - hydrogenated soybean oil (unii: a2m91m918c) (hydrogenated soybean oil - unii:a2m91m918c) - lipolytic hyperlipidemia elimination skin elasticity recovery apply to skin and massage wait for about 1 hour wash away with clean water.

United States - English - NLM (National Library of Medicine)

phytopia co., ltd. - levocarnitine (unii: 0g389fzz9m) (levocarnitine - unii:0g389fzz9m), lecithin, soybean (unii: 1di56qdm62) (lecithin, soybean - unii:1di56qdm62) - levocarnitine 210 mg in 600 mg - use for treatment of bulimia, obesity and help of weight control. directions take one capsule 60 minutes before meal, and drink at least 500ml water.

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - soybean oil (unii: 241atl177a) (soybean oil - unii:241atl177a) - soybean oil 20 g in 100 ml - nutrilipid® 20% is indicated as a source of calories and essential fatty acids for parenteral nutrition and as a source of essential fatty acids when a deficiency occurs when oral or enteral nutrition is not possible, insufficient, or contraindicated.  nutrilipid 20% injection is contraindicated in patients who have: - known hypersensitivity to egg, soybean, peanut, or any of the active or inactive ingredients in nutrilipid 20% [see warnings and precautions (5.3)]. - severe disorders of lipid metabolism characterized by hypertriglyceridemia (serum triglyceride >1,000 mg/dl) [see warnings and precautions (5.7)]. there are no adequate or well controlled studies with nutrilipid 20% in pregnant women. additionally, animal reproduction studies have not been conducted with nutrilipid 20%. it is not known whether nutrilipid 20% can cause fetal harm when administered to a pregnant woman. nutrilipid 20% should be given to a pregnant woman only if clearly needed. it is not known whether nutrilipid 20% is present in hu

Australia - English - Department of Health (Therapeutic Goods Administration)

we test bio pty ltd - 63095 - general-purpose syringe/needle - a sterile device consisting of a transparent barrel with plunger (including a needle) intended to be used for injection/withdrawal of fluids to/from a medical device or the body. it is intended for various medical applications, including medication administration. this is a single-use device.